| Literature DB >> 29605476 |
Ursula Nestle1, Dirk De Ruysscher2, Umberto Ricardi3, Xavier Geets4, Jose Belderbos5, Christoph Pöttgen6, Rafal Dziadiuszko7, Stephanie Peeters8, Yolande Lievens9, Coen Hurkmans10, Ben Slotman11, Sara Ramella12, Corinne Faivre-Finn13, Fiona McDonald14, Farkhad Manapov15, Paul Martin Putora16, Cécile LePéchoux17, Paul Van Houtte18.
Abstract
Radiotherapy (RT) plays a major role in the curative treatment of locally advanced non-small cell lung cancer (NSCLC). Therefore, the ACROP committee was asked by the ESTRO to provide recommendations on target volume delineation for standard clinical scenarios in definitive (chemo)radiotherapy (RT) and adjuvant RT for locally advanced NSCLC. The guidelines given here are a result of the evaluation of a structured questionnaire followed by a consensus discussion, voting and writing procedure within the committee. Hence, we provide advice for methods and time-points of diagnostics and imaging before the start of treatment planning and for the mandatory and optional imaging to be used for planning itself. Concerning target volumes, recommendations are given for GTV delineation of primary tumour and lymph nodes followed by issues related to the delineation of CTVs for definitive and adjuvant radiotherapy. In the context of PTV delineation, recommendations about the management of geometric uncertainties and target motion are given. We further provide our opinions on normal tissue delineation and organisational and responsibility questions in the process of target volume delineation. This guideline intends to contribute to the standardisation and optimisation of the process of RT treatment planning for clinical practice and prospective studies.Entities:
Keywords: NSCLC; Radiotherapy; Target volumes
Mesh:
Year: 2018 PMID: 29605476 DOI: 10.1016/j.radonc.2018.02.023
Source DB: PubMed Journal: Radiother Oncol ISSN: 0167-8140 Impact factor: 6.280